Podcasts
Episode 2: BTK Inhibitors for CLL and Lymphomas
07/03/2020
On this episode of Blood Bytes, a hematology podcast produced by Oncology Learning Network, John Leonard, MD, Senior Associate Dean and Professor of Hematology/Oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital, and Richard Furman, MD, Distinguished Associate Professor of Medicine and Director of CLL Research at Weill Cornell Medicine, discuss BTK inhibitors for the treatment of CLL and lymphomas.
